Vancouver, B.C., March 9, 2021 (GLOBE NEWSWIRE) – Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has signed a Letter of Intent (LOI) with ShroomBloom Labs/Floja Bioscience Inc. (“ShroomBloom”) to enter into an agreement for the supply of psychedelic mushroom biomass.
ShroomBloom is a British Columbia-based mushroom cultivator whose unique growing method uses a sustainable forest product to grow organic Psilocybe Azurescens mushrooms. Also known as Azures, they are native to British ...
Read The Full Article On StreetSignals.com
Get the latest stock market news on StreetSignals . Follow public companies and get free stock research reports and stock market analysis data and stock tips.
All content provided by StreetSignals is subject to our Terms Of Use and Disclaimer .
For further details see:
Pure Extracts and Shroombloom Sign Psychedelic Mushroom Supply Letter of Intent.